Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Cost of Revenue: 2017-2025

Historic Cost of Revenue for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $53.2 million.

  • Organogenesis Holdings' Cost of Revenue rose 10.65% to $53.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.7 million, marking a year-over-year decrease of 43.27%. This contributed to the annual value of $115.7 million for FY2024, which is 8.70% up from last year.
  • According to the latest figures from Q3 2025, Organogenesis Holdings' Cost of Revenue is $53.2 million, which was up 8.72% from $48.9 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Cost of Revenue peaked at $53.5 million during Q2 2024, and registered a low of -$36.2 million during Q4 2024.
  • Over the past 3 years, Organogenesis Holdings' median Cost of Revenue value was $27.8 million (recorded in 2023), while the average stood at $29.7 million.
  • Data for Organogenesis Holdings' Cost of Revenue shows a peak YoY increase of 103.48% (in 2024) and a maximum YoY decrease of 230.28% (in 2024) over the last 5 years.
  • Organogenesis Holdings' Cost of Revenue (Quarterly) stood at $32.6 million in 2021, then dropped by 16.83% to $27.1 million in 2022, then rose by 2.43% to $27.8 million in 2023, then crashed by 230.28% to -$36.2 million in 2024, then rose by 10.65% to $53.2 million in 2025.
  • Its Cost of Revenue stands at $53.2 million for Q3 2025, versus $48.9 million for Q2 2025 and $23.7 million for Q1 2025.